Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma 
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma
NCT05322070: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

Active, not recruiting
4
125
US
Fluocinolone Acetonide Intravitreal Implant 0.18 mg, YUTIQ 0.18 mg
Alimera Sciences, CBCC Global Research
Uveitis, Posterior
11/25
11/25
NCT05070728: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Terminated
3
12
US
Sham Injector, Sham Comparator, FAI Insert, Active Drug
EyePoint Pharmaceuticals, Inc.
Uveitis, Uveitis, Posterior, Uveitis, Intermediate
10/22
04/23

Download Options